Thomas P. O’Neill
President & CEO
Thomas P. O’Neill joined Cognivue® in April, 2018 as President and CEO. Mr. O’Neill has more than 25 years of experience leading commercial operations and a proven track record in growing revenue and EBITDA while driving operational excellence and improving customer satisfaction. Prior to joining Cognivue, Mr. O’Neill served as President, North American Commercial Operations for Qiagen, a global leader in molecular diagnostics and life sciences where he helped set the stage for long-term sustainable growth.
Prior to Qiagen, he served as the President for Hologic’s GYN, Surgical Solutions business, where he led the turnaround and significant top and bottom line growth for the Division. From 2013 to 2015, Mr. O’Neill was the President for North American Commercial Operations for Ortho Clinical Diagnostics, where he was responsible for $850 million in revenue and oversaw more than 600 professionals across all commercial functions. Under his leadership, Ortho Clinical exceeded all financial targets and restored growth to the North American business. From 2009 to 2013, Mr. O’Neill held positions of increasing responsibility at Bausch + Lomb Incorporated, most recently as Vice President and General Manager, North American Vision Care.
Prior to Bausch + Lomb, Mr. O’Neill held leadership positions at SynergEyes and Valeant Pharmaceuticals. From 1994 to 2005, he held sales and marketing positions within the Johnson and Johnson Family of Companies including Ortho-McNeil Pharmaceuticals, McNeil Consumer Healthcare and J&J/Merck. Mr. O’Neill received a B.S. in Business Administration and Marketing from the University of Akron.
Dr. Fred Ma, MD, PhD
Senior Vice President & Chief Medical Officer
Dr. Fred Ma, MD, PhD, is the Senior Vice President and Chief Medical Officer at Cognivue. His nearly four-decade career spans global medical device and pharmaceutical development and commercialization, as well as advancing neurological disorder treatments, therapies and prevention as a neurosurgeon.
Dr. Ma was most recently president and chief operating officer of Innovative Health Sciences, the immunology drug and subcutaneous drug infusion device company. He has served as chief medical officer for KORU Medical Systems, Innovacyn, and GE Healthcare, as well as leadership roles within Johnson & Johnson, Merck and elsewhere. Dr. Ma managed more than 100 new product developments with over 600 successful clinical trials and regulatory filings in the Americas, Europe, Africa and Asia-Pacific.
Before accepting his first industry position in 1990, Dr. Ma was a practicing neurosurgeon at the China-Japan Friendship Hospital in Beijing and the University of Tokyo Hospital, including tenures as attending physician and resident general chief. He received a BS/MD degree from Capital University of Medical Sciences, Beijing; a DMS (Doctor of Medical Sciences, MD/PhD) from the University of Tokyo, and a PhD in Neuroscience from Rutgers University. He is Board certified in Japan and China in neurosurgery, functional neurosurgery and oncology.
Among his many accomplishments, he has been involved in drug research and clinical investigation for cognitive modulation on ADHD, Alzheimer’s, and dementia, plus near infrared light therapy device development for TBI and PTSD.
SVP of Marketing & Channel Development
David TenBarge has over thirty years’ experience marketing diverse products in segments such as medical device, diagnostics, life sciences and pharmaceutical. David has a classical marketing background with broad commercial and direct customer experience.
Mr. TenBarge has extensive success in driving product growth by accelerated HCP adoption of new products and patient care practices. He has worked and partnered with key stakeholders in the healthcare community including healthcare providers, managed care, government, professional associations, hospitals and patient advocate groups.
David has worked with or for large healthcare organizations such as Johnson and Johnson, Sanofi®, Medtronic®, Bristol Myers Squibb®, Hologic®, Ortho Clinical Diagnostics, QIAGEN Inc. and various healthcare associations. As an entrepreneur, David has owned and operated a healthcare integrated marketing and communications organization for over thirteen years and has actively participated or led each stage of healthcare product adoption from clinical validation, market launch and outcomes tracking.
Vice President of Sales
Whitney Parachek joined Cognivue in August 2018 as Vice President of Sales. Ms. Parachek brings more than 20 years of commercial experience leading and developing high performance teams in the healthcare and device sector.
With a commitment to long term growth, she focuses on performance through the recruitment, development and engagement of high level talent. From 1999 – 2007 Ms. Parachek worked at CYTYC Corporation in various roles of increasing responsibility. In 2008 she joined the Hologic leadership team as part of the Cytyc acquisition. In 2014 she was promoted to Vice President of Sales for the Gynecologic Surgical Division and was tasked with the responsibility of turning around a declining business. During her three year tenure as VP of Sales, she was successful leading over 250 employees to drive double digit growth in a $400M business. In 2017 Whitney was promoted to Vice President Commercial Engagement responsible for ensuring the successful execution of long term strategic plans, engagement, and alignment of business unit integration.
She is driven by her passion to improve the lives of patients through innovative technologies, superior service, and valuable business solutions. Ms. Parachek earned a B.S. in Kinesiology from the College of Charleston in Charleston, South Carolina.
Paul W. Estes
Vice President of Operations and Quality
Beginning in 2009, Paul Estes helped conceive and develop Cognivue® technology, playing integral roles in de novo 510(k) clearance from the U.S. Food and Drug Administration and its commercialization.
Today, as Director of Operations and a member of the company’s leadership team, he collaborates on planning for technology roadmaps, new product development and expansion, business relations, sales team integration, and staffing. He also holds responsibility for intellectual property management, quality and regulatory affairs, manufacturing, software development, and customer training and support.
Paul has a B.S. degree in Education from Houghton College.
Vice President of National Accounts
Jeff Keys joined Cognivue® in April 2018 as Vice President of National Accounts and is a member of the leadership team. With nearly 15 years in medical device executive and sales roles, he has grown revenues and built high performing teams by focusing on the customer experience.
At Cognivue, Jeff is collaborating with integrated delivery networks and hospital groups to gain market adoption for the company’s innovative system. He is also working closely with clinical account managers on training and sales implementation to drive market penetration and growth.
Jeff previously served as area Sales Manager for Invuity, a leader in surgical photonics, and with Intuitive Surgical, where he was instrumental in growing the adoption of robotic surgery. He also held roles with Medical Action Industries, leading an eight-state sales team. Jeff holds a B.S. in Business Administration from Nazareth College.
Vice President of Market Access
Susan is an established professional with a proven background within the medical device market of helping companies with Market Access and Business/Product Development. She has a proven track record of leading contracting, account management, partner alliances, and reimbursement teams to maximize product access and reimbursement. Susan has worked at large fortune 500 companies such as Abbott and Medtronic – along with helping start-ups Therasense and Telcare become established.